Power Law company profile

Neumora Therapeutics

Biotech & Life Sciences · Waltham, United States · Founded 2020 · IPO 2023 Unicorn

Pioneering a new era of precision medicines for brain diseases

Valuation

$324M

Market cap · May/2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

16 investors on Neumora Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 13 investors entered at this stage

F-Prime

ARCH Venture Partners

Alexandria Venture Investments

Amgen

Polaris Partners

Waycross Ventures

Altitude Life Science Ventures

Mubadala Capital

Catalio Capital Management

Surveyor Capital

re.Mind Capital

Logos Capital

Invus

Series B+ 3 investors entered at this stage

Abu Dhabi Growth Fund

Newpath Management

Exor

Global footprint

Where Neumora Therapeutics has talent and traffic

AI talent share

2.7% of workforce is AI talent
(3 of 111 staff)

Core AI00%

Other AI32.7%

Non-AI workforce10897.3%

Workforce by country

2 countries with
team presence

🇺🇸 United States98.8%

🇧🇷 Brazil1.2%

2 countries shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States49.1%

🇬🇧 United Kingdom16.4%

🇨🇦 Canada14.5%

🇪🇸 Spain11.8%

🇮🇳 India4.5%

Top 5 markets shown

Patent intelligence

$66M patent portfolio · 42 active families

Estimated portfolio value

$66M

20.4% of market cap · 4.2× smaller than top peer Ascendis Pharma ($275M)

42 active patent families

Where Neumora Therapeutics innovates Medicinal chemistryPharmacologyPharmaceutical medicineMedicineData science

Where Neumora Therapeutics concentrates vs peers

Each axis is a top-10 topic across Neumora Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Neumora Therapeutics

An AI-synthesized read of the highest-engagement posts about Neumora Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Neumora Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles